Evidence map›Paper›PMID 36357000›Full record

ArticleBMJ open2022

Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China.

Junxiong Ma, Shuduo Zhou, Na Li, Xuejie Dong, Mailikezhati Maimaitiming, Dahai Yue, Yinzi Jin, Zhi-Jie Zheng

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Junxiong MaDepartment of Global Health, School of Public Health, Peking University, Beijing, China.ORCID 0000-0002-0526-713X
Shuduo ZhouDepartment of Global Health, School of Public Health, Peking University, Beijing, China.
Na LiDepartment of Global Health, School of Public Health, Peking University, Beijing, China.
Xuejie DongDepartment of Global Health, School of Public Health, Peking University, Beijing, China.
Mailikezhati MaimaitimingDepartment of Global Health, School of Public Health, Peking University, Beijing, China.ORCID 0000-0002-6559-0211
Dahai YueDepartment of Health Policy and Management, University of Maryland at College Park, College Park, Maryland, USA.
Yinzi JinDepartment of Global Health, School of Public Health, Peking University, Beijing, China yzjin@bjmu.edu.cn.ORCID 0000-0003-0634-3955
Zhi-Jie ZhengDepartment of Global Health, School of Public Health, Peking University, Beijing, China.
Peking University · CNGates Foundation · USUniversity of Maryland, College Park · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate changes in admission rates for and quality of healthcare of ST-segment-elevation myocardial infarction (STEMI) during the period of the COVID-19 outbreak and postoutbreak.

methodsWe conducted a retrospective study among patients with STEMI in the outbreak time and the postoutbreak time.

designTo examine the changes in the admission rates and in quality of healthcare, by comparison between periods of the postoutbreak and the outbreak, and between the postoutbreak and the corresponding periods.

settingData for this analysis were included from patients discharge diagnosed with STEMI from all the hospitals of Suzhou in each month of the year until the end of July 2020.

participants1965 STEMI admissions. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was the number of moecondary outcomnthly STEMI admissions, and the secondary outcomes were the quality metrics of STEMI healthcare.

resultsThere were a 53% and 38% fall in daily admissions at the phase of outbreak and postoutbreak, compared with the 2019 corresponding. There remained a gap in actual number of postoutbreak admissions at 306 and the predicted number at 497, an estimated 26 deaths due to STEMI would have been caused by not seeking healthcare. Postoutbreak period of 2020 compared with corresponding period of 2019, the percentage of cases transferred by ambulance decreased from 9.3% to 4.2% (p=0.013), the door-to-balloon median time increased from 17.5 to 34.0 min (p=0.001) and the rate of percutaneous coronary intervention (PCI) therapy declined from 71.3% to 60.1% (p=0.002).

conclusionsThe impact of public health restrictions may lead to unexpected out-of-hospital deaths and compromised quality of healthcare for acute cardiac events. Delay or absence in patients should be continuously considered avoiding the secondary disaster of the pandemic. System delay should be modifiable for reversing the worst clinical outcomes from the COVID-19 outbreak, by coordination measures with focus on the balance between timely PCI procedure and minimising contamination of cardiac catheterisation rooms.

Indexed as

COVID-19Percutaneous Coronary InterventionST Elevation Myocardial InfarctionDelivery of Health CareHumansPandemicsRetrospective StudiesTreatment OutcomeCOVID-19Myocardial infarctionQuality in health care

Identifiers

PMID36357000
PMCPMC9659714
OpenAlexW4308882679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.